Women and girls are among the key populations disproportionately affected by the HIV epidemic in Uganda, where stigma and other barriers have hindered action to roll out testing and treatment. Since the recent UPHIA HIV population-based survey, ICAP has been working with the Ministry of Health on innovative linkage and service delivery strategies for HIV prevention, care, and treatment, including pre-exposure prophylaxis (PrEP) and Test and Treat.
ICAP IN Uganda
Key Technical Areas
- Capacity building of educational institutions
- HIV prevention, care, and treatment
- Population-based surveys
- Bill & Melinda Gates Foundation
- PEPFAR / Centers for Disease Control and Prevention (CDC)
Dr. Sam Biraro
Dr. Sam Biraro is ICAP’s country representative in Uganda and leads UPHIA, the PEPFAR-supported population-based HIV impact assessment survey that is reaching 15,000 households and engaging multiple national and international stakeholders. He began his career in clinical practice with Mulago Hospital in Kampala and later with Kisiizi, a missionary hospital in rural southwestern Uganda. He then worked in clinical research with Epicentre/MSF on studies looking into strategies for HIV care and treatment and treatment of malaria. At the Medical Research Council and the Uganda Virus Research Institute, Sam conducted population-based surveillance of HIV, HSV-2, and sexually transmitted infections. Most recently, his work has focused on non-communicable diseases (NCDs), including studies into the burden of NCDs in the general population and health facility readiness to provide NCD care, as well as on an intervention to strengthen the health system in provision of NCD care. Dr. Biraro graduated as a medical doctor (MBChB) from Mbarara University and earned an MPH from Loma Linda University. He completed his PhD at the London School of Hygiene and Tropical Medicine.